Incidence of ovarian cancer after bilateral salpingo-oophorectomy in women with histologically proven endometriosis
article
OA: bronze
CC0
⤵ 7 in-corpus citations
AI-generated summary
This study investigated the incidence of ovarian cancer in women who underwent bilateral salpingo-oophorectomy for histologically confirmed endometriosis.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
ObjectiveTo assess the incidence of ovarian cancer in women with histologically proven endometriosis after bilateral salpingo-oophorectomy (BSO).DesignRetrospective nationwide cohort study.SettingDutch pathology database.Patient(s)Women with histologically proven endometriosis who had undergone BSO between 1990 and 2015 (n = 7,984). This study consists of 2 control cohorts: women with histologically proven endometriosis without BSO (n = 42,633) and women with a benign dermal nevus (n = 132,535).Intervention(s)Observational study.Main outcome measure(s)Number of histologic diagnoses of (extra-)ovarian cancers. Incidence rate ratios (IRR) were estimated for (extra-)ovarian cancer. The number needed to treat was calculated.Result(s)We identified 9 (0.1%) (extra-)ovarian cancers in the BSO cohort and 170 (0.4%) and 444 (0.3%) ovarian cancers in the endometriosis and nevus control cohorts, respectively. We found an age-adjusted IRR of 0.34 (95% confidence interval [CI], 0.15-0.76) when the BSO cohort was compared with the endometriosis cohort. Comparing the BSO cohort with the nevus control cohort resulted in an age-adjusted IRR of 0.38 (95% CI, 0.17-0.85). The number needed to treat when the BSO cohort was compared with the endometriosis control cohort was 351 (95% CI, 272-591).Conclusion(s)In this nationwide study, we found that the (extra-)ovarian cancer incidence in women with histologically proven endometriosis decreased to less than the background population risk after BSO. Additionally, we found a significant reduction of the incidence of ovarian cancer when compared with women with histologically proven endometriosis without BSO. Endometriosis surgery could in the future be a preventive strategy in women with endometriosis and a high-risk profile for ovarian cancer.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (20)
- Endometriosis and cancer: a systematic review and meta-analysis via openalex
- Epidemiology of endometriosis: a large population‐based database study from a healthcare provider with 2 million members via openalex
- Hormonal and surgical treatments for endometriosis and risk of epithelial ovarian cancer via openalex
- Immunologic factors involved in the malignant transformation of endometriosis to endometriosis-associated ovarian carcinoma via openalex
- Incidence of endometrioid and clear-cell ovarian cancer in histological proven endometriosis: the ENOCA population-based cohort study via openalex
- Incidence of Laparoscopically Confirmed Endometriosis by Demographic, Anthropometric, and Lifestyle Factors via openalex
- Increased incidence of ovarian cancer in both endometriosis and adenomyosis via openalex
- Risk factors of epithelial ovarian carcinomas among women with endometriosis: a systematic review via openalex
- Risk of Gynecologic Cancer According to the Type of Endometriosis via openalex
- W6603743216 via openalex
- W1982900907 via openalex
- W6747063688 via openalex
- W2119913499 via openalex
- W2404782822 via openalex
- W2780553007 via openalex
- W2807649309 via openalex
- W2889646458 via openalex
- W2909791732 via openalex
- W2966505635 via openalex
- W3162975920 via openalex
Cited by (8)
- Guideline No. 468: Clinical Management of Endometriosis 2026
- Lignes directrices de pratique clinique n° 468 : Prise en charge clinique de l'endométriose 2026
- The Occurrence and Histopathological Recognition of Atypical Endometriosis in Patients with Ovarian Endometriosis – a Retrospective Cohort Study 2025
- The occurrence and histopathological recognition of atypical endometriosis in patients with ovarian endometriosis - a retrospective cohort study 2025
- The Optimal Age for Oophorectomy in Women with Benign Conditions: A Narrative Review 2025
- Endometriosis as a risk factor for ovarian cancer: an update on screening, risk reduction, treatment and prognosis 2024
- DRUG THERAPIES IN THE TREATMENT OF ENDOMETRIOSIS 2023
- Endometriosis: not just a benign disease 2022
Source provenance
- europepmc
- last seen: 2026-08-04T06:16:37.499272+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-20T00:35:15.096393+00:00
License: CC0
· commercial use OK